BioCentury | Sep 14, 2018
Company News

Telo, GSK targeting TERT to halt glioblastoma cell immortality

...UCSF or Telo held any IP surrounding the paper's findings. Telo Therapeutics Inc., San Francisco, Calif. Mark Zipkin GlaxoSmithKline plc Telo Therapeutics Inc. University...
Items per page:
1 - 1 of 1
BioCentury | Sep 14, 2018
Company News

Telo, GSK targeting TERT to halt glioblastoma cell immortality

...UCSF or Telo held any IP surrounding the paper's findings. Telo Therapeutics Inc., San Francisco, Calif. Mark Zipkin GlaxoSmithKline plc Telo Therapeutics Inc. University...
Items per page:
1 - 1 of 1